SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.61    0.41 (18.64%)
Bid:
2.62
Ask:
2.90
Spread: 0.28 (10.687%)
Market Cap: £4.76m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Litigation update

12 Jan 2026 07:00

RNS Number : 4691O
Nanoco Group PLC
12 January 2026
 

FOR IMMEDIATE RELEASE 12 January 2026

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (596/2014/EU) AS THE SAME HAS BEEN RETAINED IN UK LAW AS AMENDED BY THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR").

Nanoco Group PLC

("Nanoco", the "Group", or the "Company")

 

Litigation update

 

Nanoco seeks damages for infringement of IP by Shoei

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform has filed an answer and counterclaims to the complaint for declaratory judgement originally filed by Shoei Chemical Inc. and Shoei Electronic Materials, Inc. (together, "Shoei") in the US District Court for the Eastern District of Virginia.

As detailed in the Group announcement on 27 November 2025, Shoei filed a declaratory judgement action claiming it is not infringing a number of Nanoco's patents.

Subsequently, the Board has evaluated next steps with legal counsel and concluded that it has a number of counterclaims against Shoei for infringement of Nanoco's intellectual property. As part of the counterclaims, Nanoco seeks damages for infringement of U.S. Patent No. 7,588,828, US Patent No. 7,803,423, US Patent No. 7,867,557 and US Patent No. 8,524,365.

Shoei acquired substantially all of the assets from Nanosys, Inc. ("Nanosys"), another manufacturer of quantum dots, for an undisclosed sum in September 2023. Shoei is a supplier of quantum dots to a number of globally significant technology companies. At this stage, the counterclaims do not specify the quantum of monetary damages sought by Nanoco and it may take some time before this is established.

Nanoco has retained Caldwell, Cassady and Curry ("CCC"), an IP law firm based in Dallas, Texas, USA, to represent it in patent enforcement and litigation. CCC was one of the legal firms involved in Nanoco's successful litigation against both Samsung and LG Electronics.

This case is expected to come to trial within the calendar year 2026 and is currently being funded from the Group's existing cash reserves. Shareholders are reminded that there can be no guarantee of success in a lawsuit, or as to the monetary damages that may be awarded if the jury and/or court finds in favour of Nanoco.

The Board of Nanoco will continue to update shareholders as appropriate.

 

Dr Jalal Bagherli, Nanoco's Chairman, commented:

"Nanoco has on multiple occasions proven the value and validity of its IP through the Samsung and LG litigation processes. As a Board, we have been clear in our commitment to defending our IP to ensure a fair outcome for shareholders of Nanoco, and have the financial resources to do so.

 

As with previous litigation that the Board has overseen, while there is potential for damages, litigation itself carries considerable inherent risk and the Board must weigh the opportunity versus the cost. Having taken legal advice and given Shoei's position in the global technology supply chain, the Board believes that it is in the best interests of shareholders to both defend the Shoei claims of non-infringement, and pursue counter claims for infringement.

 

 

- Ends -

MAR

The information contained within this announcement is considered by the Company to contain inside information for the purposes of UK MAR. Upon the publication of this announcement via a Regulatory Information Service, this inside information will be considered to be in the public domain.

The person responsible for arranging for the release of this announcement on behalf of Nanoco is Liam Gray, Chief Financial Officer.

 

Nanoco Group plc:

Dmitry Shashkov, CEO +44 (0)1928 761 404

Liam Gray, CFO & Company Secretary

 

Sodali & Co (Public Relations)

Elly Williamson +44 (0)79 3535 1934

Pete Lambie

Oliver Banks

Nanoco@sodali.com

 

Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker):

Ed Frisby / George Lawson (Corporate Finance) +44 (0) 20 7220 0500

Tim Redfern (Corporate Broking)

Jasper Berry (Sales)

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) is a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from its technology platform. In particular, Nanoco is a nanomaterial production and licensing group, specialising in the production of its patented cadmium free quantum dots (CFQD® materials) and other patented nanomaterials for use in the electronics industries. Founded in 2001 and headquartered in Runcorn, UK, Nanoco continues to build out a world-class, patent-protected IP portfolio alongside its existing scaled up production facilities for commercial orders.

Nanomaterials are materials with dimensions typically in the range 1 - 100 nm. Nanomaterials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nanomaterial that have size-dependent optical and electronic properties. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Sensor, Electronics and Display markets. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of display applications. Nanoco's HEATWAVE® quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectra, rendering them useful for applications including cameras and image sensors.

Nanoco is listed on the Main Market of the London Stock Exchange, holds the LSE's Green Economy Mark, and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFFFAFEMSEDF
Date   Source Headline
15th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jul 20247:00 amRNSHolding(s) in Company
11th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:01 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20247:00 amRNSYear End Trading Update
1st Jul 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSBlocklisting Six Monthly Return
31st May 20245:19 pmRNSTotal Voting Rights and Share Capital
9th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Apr 20244:06 pmRNSTR-1: Notification of Major Holdings
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20243:02 pmRNSExercise of Deferred Bonus Options
18th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20241:56 pmRNSNotification of Major Holdings
17th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Apr 20244:10 pmRNSDirector/PDMR Shareholding
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Apr 20247:00 amRNSResult of Tender Offer
28th Mar 202412:52 pmRNSGeneral Meeting - Voting Results
27th Mar 20247:00 amRNSInterim Results
11th Mar 202412:47 pmRNSPosting of Circular
11th Mar 20247:00 amRNSProposed return of up to £33.0 million
8th Feb 20247:00 amRNSHalf Year Trading Update
7th Feb 202411:23 amRNSDirector Declaration
24th Jan 20247:00 amRNSReceipt of Final Litigation Proceeds
23rd Jan 20244:02 pmRNSNotification Of Transactions By PDMR
16th Jan 20243:40 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
12th Jan 20249:45 amRNSJoint Development Agreement with European Customer
22nd Dec 20237:00 amRNSAppointment of Financial Adviser and Joint Broker
21st Dec 202312:00 pmRNSAppointments of Non-Executive Directors
12th Dec 20239:35 amRNSBlocklisting six-monthly return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.